Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Researchers report that an existing experimental compound, CGP3466B, activates the same signalling pathway involved in ketamine’s antidepressive actions. In the image, ketamine crystals

A drug that mimics the effects of ketamine (pictured) could be used as a new fast-acting antidepressant

Source  M. I. Walker / Science Photo Library